全国服务咨询热线:
18501609238
18501609238
AOA体育相关的文章
Related Articles详细介绍
| 品牌 | 其他品牌 | 供货周期 | 现货 |
|---|---|---|---|
| 应用领域 | 医疗卫生,环保,食品,化工,生物产业 |
Biovisoin代理销售 3861BP-50
Biovisoin代理销售 3861BP-50
| 3861BP-50 | SOCS1 Blocking Peptide |
| 3871BP-50 | SEK1/MKK4/JKK1 Blocking Peptide |
| 3873BP-50 | Furin/PACE Blocking Peptide |
| 3874BP-50 | Relaxin-1 Blocking Peptide |
| 3875BP-50 | SCD Blocking Peptide |
| 3880BP-50 | FKBP52/Hsp56 Blocking Peptide |
| 3881BP-50 | Notch 1 Blocking Peptide |
| 3882BP-50 | Mitofusin 2 Blocking Peptide |
| 3883BP-50 | Sphingosine Kinase 1 (SPK1) Blocking Peptide |
| 3884BP-50 | Sphingosine Kinase 2 (SPK2) Blocking Peptide |
| 3885BP-50 | TFAM Blocking Peptide |
| 3886BP-50 | Apg5/Atg Blocking Peptide |
| 3887BP-50 | Sp3 Blocking Peptide |
| 3888BP-50 | Boris Blocking Peptide |
| 3889BP-50 | Sox-2 Blocking Peptide |
| 3890BP-50 | OX40 Blocking Peptide |
| 3891BP-50 | Dectin-1 Blocking Peptide |
| 3892BP-50 | FoxH1 Blocking Peptide |
| 3893BP-50 | DKK3 Blocking Peptide |
| 3894BP-50 | DKK4 Blocking Peptide |
| 3895BP-50 | BLAME Blocking Peptide |
| 3896BP-50 | CLOCK Blocking Peptide |
| 3897BP-50 | NFkB p105 Blocking Peptide |
| 3898BP-50 | DPP10 Blocking Peptide |
| 3899BP-50 | Hemopexin Blocking Peptide |
| 3900BP-50 | LAMP2 Blocking Peptide |
| 3901BP-50 | CGI-58 Blocking Peptide |
| 3903BP-50 | Relaxin-2 Blocking Peptide |
| 3904BP-50 | EDEM1 Blocking Peptide |
| 3905BP-50 | Rabex-5 Blocking Peptide |
| 3906BP-50 | Serpin A6 Blocking Peptide |
| 3907BP-50 | APG7/ATG7 Blocking Peptide |
| 3908BP-50 | PAK1 Blocking Peptide |
| 3912BP-50 | APG12/ATG12 Blocking Peptide |
| 3916BP-50 | APG16/ATG16 Blocking Peptide |
| 3917BP-50 | Beta-Actin Blocking Peptide |
| 3923BP-50 | EMP-3 Blocking Peptide |
| 3924BP-50 | Influenza A Virus Hemagglutinin (HA) Blocking Peptide |
| 3925BP-50 | Alpha-Amylase Blocking Peptide |
| 3926BP-50 | ICAM-2 Blocking Peptide |
| 3927BP-50 | PAK6 Blocking Peptide |
| 3928BP-50 | PAK5/PAK7 Blocking Peptide |
| 3929BP-50 | PINK1 Blocking Peptide |
| 3930BP-50 | BMI-1 Blocking Peptide |
| 3931BP-50 | TLR11 Blocking Peptide |
| 3932BP-50 | TLR10 Blocking Peptide |
| 3934BP-50 | PGC-1 alpha Blocking Peptide |
| 3935BP-50 | PRMT-5 Blocking Peptide |
| 3936BP-50 | MC4 Receptor Blocking Peptide |
| 3937BP-50 | Adipsin Blocking Peptide |
| 3938BP-50 | ALK7 Blocking Peptide |
| 3939BP-50 | β3-AR Blocking Peptide |
| 3940BP-50 | AdipoR1 Blocking Peptide |
| 3941BP-50 | TP2 Blocking Peptide |
| 3942BP-50 | Histone Methyltransferase (SUV39H1) Blocking Peptide |
| 3943BP-50 | C/EBP-alpha Blocking Peptide |
| 3944BP-50 | Pyruvate Dehydrogenase Phosphatase 2 (PDP 2) Blocking Peptide |
| 3945BP-50 | GLUT4 Blocking Peptide |
| 3946BP-50 | DNMT1 Blocking Peptide |
| 3947BP-50 | LPL Blocking Peptide |
| 3948BP-50 | Perilipin A Blocking Peptide |
| 3949BP-50 | PEPCK-C Blocking Peptide |
| 3950BP-50 | LKB1 Blocking Peptide |
| 3951BP-50 | AMPK Blocking Peptide |
| 3952BP-50 | HMG-CoA Blocking Peptide |
| 3953BP-50 | TORC2 Blocking Peptide |
| 3954BP-50 | AS160/TBC1 Blocking Peptide |
| 3955BP-50 | TSC1 Blocking Peptide |
| 3956BP-50 | PDE3B Blocking Peptide |
| 3957BP-50 | Rictor Blocking Peptide |
| 3958BP-50 | S-100 Blocking Peptide |
| 3959BP-50 | PI3K Blocking Peptide |
| 3960BP-50 | CBP-Tag Blocking Peptide |
| 3961BP-50 | SREBP1 Blocking Peptide |
| 3962BP-50 | TSC2 Blocking Peptide |
| 3971BP-50 | Sin1 Blocking Peptide |
| 3986BP-50 | SBP-Tag Blocking Peptide |
| 3988BP-50 | Strep-Tag II Blocking Peptide |
| 3989BP-50 | DYKDDDDK-Tag Blocking Peptide |
| 3990BP-50 | S-Tag Blocking Peptide |
| 3995BP-50 | Myc-Tag Blocking Peptide |
| 3998BP-50 | His-Tag Blocking Peptide |
| 5094RBP-50 | G-CSF Blocking Peptide |
| 5098BP-50 | GDNF Blocking Peptide |
| 5179BP-50 | IL-18 Blocking Peptide |
| 5212BP-50 | KC Blocking Peptide |
| 5343RBP-50 | TGF-beta2 Blocking Peptide |
| 5344RBP-50 | TGF-beta3 Blocking Peptide |
| 5390BP-50 | SDF-1beta Blocking Peptide |
| 5537RBP-50 | CX3CR1/RBS11 Blocking Peptide |
| 5541BP-50 | CXCR4 Blocking Peptide |
| 5559BP-50 | TGF-β1 Blocking Peptide |
| 5570RBP-50 | DAP12 Blocking Peptide |
| 5571BP-50 | MIF Blocking Peptide |
| 5580BP-50 | BMP-14 Blocking Peptide |
| 5636RBP-50 | TGF-beta Receptor I Blocking Peptide |
| 5639RBP-50 | TGF-beta Receptor II Blocking Peptide |
| 5648BP-50 | TCR alpha Blocking Peptide |
| 5651BP-50 | TCR beta Blocking Peptide |
| 5673RBP-50 | BMP-3 Blocking Peptide |
| 5674RBP-50 | BMP-4 Blocking Peptide |
| 5675RBP-50 | BMP-5 Blocking Peptide |
| 5990BP-50 | Ghrelin Blocking Peptide (N3 modified) |
| 5991BP-50 | Ghrelin Blocking Peptide (c-terminus) |
| 5992BP-50 | Ghrelin Blocking Peptide |
| 6008BP-50 | Synapsin Blocking Peptide |
| 6281BP-50 | BRD2 Blocking Peptide |
| 6282BP-50 | BRD3 Blocking Peptide |
| 6283BP-50 | BRD4 Blocking Peptide |
| 6284BP-50 | ACTL6A Blocking Peptide |
| 6285BP-50 | Swi6 Blocking Peptide |
| 6633BP-50 | EDEM2 Blocking Peptide |
| 6656BP-50 | SPHKAP Blocking Peptide |
| 6657BP-50 | PSGL-1 Blocking Peptide |
| 6658BP-50 | USP8 Blocking Peptide |
| 6678BP-50 | EHHADH Blocking Peptide |
| 3160BP-50 | Survivin Blocking Peptide |
| 3362BP-50 | Cox-2 Blocking Peptide |
| 1007-1000 | Caspase-3 Substrate DEVD-AFC |
| 1007-200 | Caspase-3 Substrate DEVD-AFC |
| 1008-1000 | Caspase-3 Substrate DEVD-pNA |
| 1008-200 | Caspase-3 Substrate DEVD-pNA |
| 1009-100 | Caspase-3 Inhibitor Z-DEVD-FMK |
| 1009-20C | Caspase-3 Inhibitor Z-DEVD-FMK |
| 1010-100 | Caspase-Family Inhibitor Z-VAD-FMK |
| 1010-20C | Caspase-Family Inhibitor Z-VAD-FMK |
| 1011-100 | Caspase-6 Inhibitor Z-VEID-FMK |
| 1011-20C | Caspase-6 Inhibitor Z-VEID-FMK |
| 1012-100 | Caspase-1 Inhibitor Z-YVAD-FMK |
| 1012-20C | Caspase-1 Inhibitor Z-YVAD-FMK |
| 1032-20C | Biotin-VDVAD-FMK |
| 1036-50 | Actinomycin D (10 mM) |
| 1036-50MG | Actinomycin D |
| 1036-5MG | Actinomycin D |
| 1039-1 | Camptothecin (2 mg/ml) |
| 1039-500MG | Camptothecin |
| 1039-50MG | Camptothecin |
| 1041-1 | Cycloheximide (100 mM) |
| 1041-1G | Cycloheximide |
| 1041-5G | Cycloheximide |
| 1042-1 | Dexamethasone (10 mM) |
| 1042-10G | Dexamethasone |
| 1042-1G | Dexamethasone |
| 1043-100 | Etoposide (100 mM) |
| 1043-250MG | Etoposide |
| 1043-25MG | Etoposide |
| 1048-01 | Staurosporine |
| 1048-1 | Staurosporine |
| 1056-1 | Propidium Iodide |
| 1062-1000 | Caspase-8 Substrate IETD-AFC |
| 1062-200 | Caspase-8 Substrate IETD-AFC |
| 1063-1000 | Caspase-8 Substrate IETD-pNA |
| 1063-200 | Caspase-8 Substrate IETD-pNA |
| 1064-100 | Caspase-8 Inhibitor Z-IETD-FMK |
| 1064-20C | Caspase-8 Inhibitor Z-IETD-FMK |
| 1069-1000 | Caspase-6 Substrate VEID-AFC |
| 1069-200 | Caspase-6 Substrate VEID-AFC |
| 1070-1000 | Caspase-6 Substrate VEID-pNA |
| 1070-200 | Caspase-6 Substrate VEID-pNA |
| 1071-1000 | Caspase-2 Substrate VDVAD-AFC |
| 1071-200 | Caspase-2 Substrate VDVAD-AFC |
| 1072-1000 | Caspase-2 Substrate VDVAD-pNA |
| 1072-200 | Caspase-2 Substrate VDVAD-pNA |
| 1073-100 | Caspase-2 Inhibitor Z-VDVAD-FMK |
| 1073-20C | Caspase-2 Inhibitor Z-VDVAD-FMK |
| 1074-100 | Caspase-9 Inhibitor Z-LEHD-FMK |
| 1074-20C | Caspase-9 Inhibitor Z-LEHD-FMK |
| 1075-1000 | Caspase-9 Substrate LEHD-AFC |
| 1075-200 | Caspase-9 Substrate LEHD-AFC |
| 1076-1000 | Caspase-9 Substrate LEHD-pNA |
| 1076-200 | Caspase-9 Substrate LEHD-pNA |
| 1077-100 | AFC (7-amino-4-trifluoromethyl-coumarin) |
| 1078-100 | pNA (p-nitroaniline) |
| 1079-100 | Caspase-12 Inhibitor Z-ATAD-FMK |
| 1079-20C | Caspase-12 Inhibitor Z-ATAD-FMK |
| 1100-100 | Caspase-5 Inhibitor Z-WEHD-FMK |
| 1100-20C | Caspase-5 Inhibitor Z-WEHD-FMK |
| 1101-1000 | Caspase-5 Substrate WEHD-AFC |
| 1101-200 | Caspase-5 Substrate WEHD-AFC |
| 1102-1000 | Caspase-5 Substrate WEHD-pNA |
| 1102-200 | Caspase-5 Substrate WEHD-pNA |
| 1103-1000 | Caspase-1 Substrate YVAD-AFC |
| 1103-200 | Caspase-1 Substrate YVAD-AFC |
| 1104-1000 | Caspase-1 Substrate YVAD-pNA |
| 1104-200 | Caspase-1 Substrate YVAD-pNA |
| 1108-100 | Caspase-4 Inhibitor Z-LEVD-FMK |
| 1108-20C | Caspase-4 Inhibitor Z-LEVD-FMK |
| 1109-1000 | Caspase-4 Substrate LEVD-AFC |
| 1109-200 | Caspase-4 Substrate LEVD-AFC |
| 1110-1000 | Caspase-4 Substrate LEVD-pNA |
| 1110-200 | Caspase-4 Substrate LEVD-pNA |
| 1112-100 | Caspase-10 Inhibitor AEVD-FMK |
| 1112-20C | Caspase-10 Inhibitor AEVD-FMK |
| 1113-1000 | Caspase-10 Substrate AEVD-AFC |
| 1113-200 | Caspase-10 Substrate AEVD-AFC |
| 1114-1000 | Caspase-10 Substrate AEVD-pNA |
| 1114-200 | Caspase-10 Substrate AEVD-pNA |
| 1115-100 | Caspase-13 Inhibitor LEED-FMK |
| 1115-20C | Caspase-13 Inhibitor LEED-FMK |
| 1116-1000 | Caspase-13 Substrate LEED-AFC |
| 1116-200 | Caspase-13 Substrate LEED-AFC |
| 1117-1000 | Caspase-12 Substrate ATAD-AFC |
| 1117-200 | Caspase-12 Substrate ATAD-AFC |
| 1119-1 | Granzyme B Inhibitor Ac-IEPD-CHO |
| 1120-20C | Caspase Inhibitor Boc-D-FMK |
| 1121-20C | Biotin-IETD-FMK |
| 1122-100 | FMK Negative Control |
| 1122-20C | FMK Negative Control |
| 1123-20C | Biotin-VAD-FMK |
| 1124-20C | Biotin-DEVD-FMK |
| 1125-20C | Calpain Inhibitor Z-LLY-FMK |
| 1126-20C | Cathepsin B&L Inhibitor Z-Phe-Phe-FMK |
| 1127-20C | EMAP-II Inhibitor Z-ASTD-FMK |
| 1128-20C | Granzyme B Inhibitor Z-AAD-CH2Cl |
| 1130-5 | JC-1 |
| 1131-1 | D2R [(L-Asp)2 rhodamine 110] |
| 1140-1 | Z-VAD-FMK |
| 1140-5 | Z-VAD-FMK |
| 1141-1 | Z-YVAD-FMK |
| 1141-5 | Z-YVAD-FMK |
| 1142-1 | Z-VDVAD-FMK |
| 1142-5 | Z-VDVAD-FMK |
| 1143-1 | Z-DEVD-FMK |
| 1143-5 | Z-DEVD-FMK |
| 1144-1 | Z-LEVD-FMK |
| 1144-5 | Z-LEVD-FMK |
| 1146-1 | Z-VEID-FMK |
| 1146-5 | Z-VEID-FMK |
| 1148-1 | Z-IETD-FMK |
| 1148-5 | Z-IETD-FMK |
| 1149-1 | Z-LEHD-FMK |
| 1149-5 | Z-LEHD-FMK |
| 1152-1 | Z-ATAD-FMK |
| 1152-5 | Z-ATAD-FMK |
| 1160-1 | Boc-D-FMK |
| 1160-5 | Boc-D-FMK |
| 1170-1 | Q-VD-OPh |
| 1170-3 | Q-VD-OPh |
| 1170-5 | Q-VD-OPh |
| 1171-1 | QVD-OPh Negative Control |
| 1171-3 | QVD-OPh Negative Control |
| 1171-5 | QVD-OPh Negative Control |
| 1173-1 | EZSolution™ Q-VD-OPh |
| 1174-1 | EZSolution™ Q-VD-OPh, Negative Control |
| 1175-1 | Caspase-3 Inhibitor Q-DEVD-OPh |
| 1175-3 | Caspase-3 Inhibitor Q-DEVD-OPh |
| 1175-5 | Caspase-3 Inhibitor Q-DEVD-OPh |
| 1176-1 | Caspase-8 Inhibitor, Q-IETD-OPh |
| 1176-3 | Caspase-8 Inhibitor, Q-IETD-OPh |
| 1176-5 | Caspase-8 Inhibitor, Q-IETD-OPh |
| 1177-1 | Caspase-9 Inhibitor, Q-LEHD-OPh |
| 1177-3 | Caspase-9 Inhibitor, Q-LEHD-OPh |
| 1177-5 | Caspase-9 Inhibitor, Q-LEHD-OPh |
| 1178-1 | EZSolution™ Q-DEVD-OPh |
| 1201-1 | DTT |
| 1202-10G | TCEP.HCl |
| 1202-1ML | TCEP.HCl |
| 1203-10 | Ethidium Bromide |
| 1209-10 | Trypan Blue (0.4%) |
| 1210-200 | Wash Buffer |
| 1212-100 | ABTS™ |
| 1215-100 | TMB, Ultrasensitive |
| 1216-100 | TMB, High Kinetics |
| 1241-1 | Oxidized Glutathione (GSSG) |
| 1242-1 | Reduced Glutathione (GSH) |
| 1501-10 | A23187 |
| 1505-100 | Arachidonic Acid |
| 1506-1000 | Aurintricarboxylic acid |
| 1519-1000 | Colchicine |
| 1522-100 | Cyclosporine A |
| 1522-1G | Cyclosporine A |
| 1524-10 | Daunorubicin.HCl |
| 1524-50 | Daunorubicin.HCl |
| 1524-500 | Daunorubicin.HCl |
| 1527-5 | Doxorubicin.HCl |
| 1531-5 | Forskolin |
| 1531-25 | Forskolin |
| 1533-10 | Genistein |
| 1533-100 | Genistein |
| 1535-10 | Genistin |
| 1543-025 | Okadaic acid |
| 1543-100 | Okadaic acid |
| 1544-5 | Phorbol-12-myristate 13-acetate (PMA) |
| 1545-10G | CHAPS, High Purity |
| 1545-50G | CHAPS, High Purity |
| 1545-100G | CHAPS, High Purity |
| 1545-500G | CHAPS, High Purity |
| 1545-1Kg | CHAPS, High Purity |
| 1547-1 | FAS Inhibitor, C75 |
| 1548-5 | PMSF |
| 1548-25 | PMSF |
| 1549-10 | Anisomycin |
| 1550-100 | Cisplatin |
| 1550-1000 | Cisplatin |
| 1551-1000 | Tamoxifen citrate |
| 1552-100 | Betulinic acid |
| 1552-25 | Betulinic acid |
| 1553-100 | Carboplatin |
| 1554-10 | Pifithrin-ɑ |
| 1555R-1000 | GST Inhibitor-1 (Cibacron Blue 3G-A, Sodium Salt) |
| 1556-1000 | GST Inhibitor-2 (Ethacrynic acid)) |
| 1557-1G | G418 Sulfate |
| 1557-25G | G418 Sulfate |
| 1557-5G | G418 Sulfate |
| 1558-1 | Thapsigargin |
| 1559-5 | Rosiglitazone |
| 1559-50 | Rosiglitazone |
| 1559-100 | Rosiglitazone |
| 1560-5 | Brefeldin A |
| 1560-50 | Brefeldin A |
| 1561-50 | Mifepristone |
| 1562-025 | Calyculin A |
| 1563-1 | FK-506 |
| 1563-10 | FK-506 |
| 1564-1 | Geldanamycin |
| 1564-5 | Geldanamycin |
| 1565-1 | Ionomycin (free acid) |
| 1565-5 | Ionomycin (free acid) |
| 1566-1 | Ionomycin (Calcium salt) |
| 1566-5 | Ionomycin (Calcium salt) |
| 1567-25 | Paclitaxel |
| 1568-5 | Rapamycin |
| 1568-50 | Rapamycin |
| 1570-5 | Tyrphostin AG 490 |
| 1571-5 | Tyrphostin AG 1295 |
| 1572-10-5 | OxiRed™ Probe |
| 1572-20-5 | OxiRed™ Probe |
| 1572-5 | OxiRed™ Probe |
| 1573-2 | Ascomycin |
| 1574-100 | Celecoxib |
| 1574-1000 | Celecoxib |
| 1575-5 | Bexarotene |
| 1575-50 | Bexarotene |
| 1576-5 | Nedaplatin |
| 1577-25 | Oxaliplatin |
| 1578-5 | Cyclopamine |
| 1579-5 | Cerulenin |
| 1579-50 | Cerulenin |
| 1580-100 | GSNO |
| 1580-25 | GSNO |
| 1581-25 | Axitinib (AG-013736) |
| 1581-5 | Axitinib (AG-013736) |
| 1582-25 | Saracatinib (AZD0530) |
| 1582-5 | Saracatinib (AZD0530) |
| 1583-25 | Aurora Kinase B Inhibitor (AZD1152-HQPA) |
| 1583-5 | Aurora Kinase B Inhibitor (AZD1152-HQPA) |
| 1584-25 | Bosutinib (SKI-606) |
| 1584-5 | Bosutinib (SKI-606) |
| 1585-25 | PD184352 |
| 1585-5 | PD184352 |
| 1585-1 | PD184352 |
| 1586-100 | Dasatinib (BMS-354825, Sprycel) |
| 1586-25 | Dasatinib (BMS-354825, Sprycel) |
| 1587-25 | Deforolimus |
| 1587-5 | Deforolimus |
| 1588-100 | Erlotinib, Hydrochloride Salt |
| 1588-1000 | Erlotinib, Hydrochloride Salt |
| 1589-25 | Gefitinib |
| 1589-5 | Gefitinib |
| 1590-1 | MS-275 (Entinostat, SNDX-275) |
| 1590-5 | MS-275 (Entinostat, SNDX-275) |
| 1591-1 | NVP-AUY922 |
| 1591-5 | NVP-AUY922 |
| 1592-25 | Perifosine (KRX-0401) |
| 1592-5 | Perifosine (KRX-0401) |
| 1593-25 | Pimecrolimus |
| 1593-5 | Pimecrolimus |
| 1594-100 | BAY 43-9006 |
| 1594-25 | BAY 43-9006 |
| 1595-100 | Tozasertib (VX-680, MK-0457, VX6) |
| 1595-25 | Tozasertib (VX-680, MK-0457, VX6) |
| 1596-1 | Y-27632, dihydrochloride |
| 1596-5 | Y-27632, dihydrochloride |
| 1596-50 | Y-27632, dihydrochloride |
| 1598-1 | VX-702 |
| 1598-5 | VX-702 |
| 1599-1 | Vicriviroc Malate |
| 1599-5 | Vicriviroc Malate |
| 1600-25 | Temsirolimus (CCI-779, Torisel) |
| 1600-5 | Temsirolimus (CCI-779, Torisel) |
| 1601-1 | Apicidin |
| 1604-1 | SAHA |
| 1604-5 | SAHA |
| 1605-1 | Scriptaid |
| 1606-1 | Trichostatin A |
| 1607-1 | M344 |
| 1608-100 | Sodium 4-phenylbutyrate |
| 1608-1000 | Sodium 4-phenylbutyrate |
| 1609-1000 | Sodium butyrate |
| 1610-5 | Splitomicin |
| 1611-25 | Sunitinib Malate (Sutent) |
| 1611-100 | Sunitinib Malate (Sutent) |
| 1611-1000 | Sunitinib Malate (Sutent) |
| 1612-1 | Panobinostat (LBH589) |
| 1612-5 | Panobinostat (LBH589) |
| 1612-25 | Panobinostat (LBH589) |
| 1613-1 | Cediranib (AZD2171) |
| 1613-5 | Cediranib (AZD2171) |
| 1614-1 | BMS-599626 |
| 1614-5 | BMS-599626 |
| 1615-1 | ABT-869 |
| 1615-5 | ABT-869 |
| 1616-1 | BIBW2992 (Tovok) |
| 1616-5 | BIBW2992 (Tovok) |
| 1617-5 | Canertinib (CI-1033, PD-183805) |
| 1617-50 | Canertinib (CI-1033, PD-183805) |
| 1618-25 | Fingolimod (FTY-720A, FTY720) |
| 1618-5 | Fingolimod (FTY-720A, FTY720) |
| 1619-1 | Enzastaurin (LY317615) |
| 1619-5 | Enzastaurin (LY317615) |
| 1620-1 | ABT-888 |
| 1620-5 | ABT-888 |
| 1622-25 | CP-690550 |
| 1622-5 | CP-690550 |
| 1623-1 | GDC-0941 |
| 1623-5 | GDC-0941 |
| 1624-100 | Lapatinib Ditosylate (Tykerb, Tyverb, GW-572016) |
| 1624-25 | Lapatinib Ditosylate (Tykerb, Tyverb, GW-572016) |
| 1625-100 | Imatinib Mesylate (CGP-57148B, STI-571) |
| 1625-1000 | Imatinib Mesylate (CGP-57148B, STI-571) |
| 1626-25 | BEZ235 (NVP-BEZ235) |
| 1626-5 | BEZ235 (NVP-BEZ235) |
| 1643-2 | PD-0325901 |
| 1643-5 | PD-0325901 |
| 1643-25 | PD-0325901 |
| 1644-1000 | AEBSF.HCl |
| 1644-200 | AEBSF.HCl |
| 1645-05 | SU-5402 |
| 1645-1 | SU-5402 |
| 1646-25G | n-Octyl-β-D-glucopyranoside |
| 1646-50G | n-Octyl-β-D-glucopyranoside |
| 1646-5G | n-Octyl-β-D-glucopyranoside |
| 1647-200 | Valproic Acid, Sodium Salt |
| 1648-100 | Leupeptin, hemisulfate (Microbial) |
| 1648-25 | Leupeptin, hemisulfate (Microbial) |
| 1648-50 | Leupeptin, hemisulfate (Microbial) |
| 1649-1G | IPTG, Animal-Free (Dioxane-Free) |
| 1649-50G | IPTG, Animal-Free (Dioxane-Free) |
| 1649-5G | IPTG, Animal-Free (Dioxane-Free) |
| 1651-10 | SIRT2 Inhibitor, AGK2 |
| 1652-10 | SIRT1 Inhibitor, EX-527 |
| 1653-10 | Cambinol |
| 1654-10 | PAC-1 |
| 1655-2 | GSK-3β Inhibitor, TWS119 |
| 1656-2 | PD 153035 Hydrochloride |
| 1657-5 | Compound 401 |
| 1658-1 | PP242 |
| 1659-1 | Hh Signaling Pathway Antagonist |
| 1660-1 | TGX-115 |
| 1661-1 | IC87114 |
产品咨询
电话
微信扫一扫
当前位置：
地址：上海市奉贤区金大公路8218号1幢
邮箱：yihbio@163.com
传真：021-62962298